全文获取类型
收费全文 | 11108篇 |
免费 | 1018篇 |
国内免费 | 48篇 |
专业分类
耳鼻咽喉 | 23篇 |
儿科学 | 382篇 |
妇产科学 | 17篇 |
基础医学 | 1307篇 |
口腔科学 | 28篇 |
临床医学 | 327篇 |
内科学 | 231篇 |
皮肤病学 | 7717篇 |
神经病学 | 34篇 |
特种医学 | 181篇 |
外科学 | 214篇 |
综合类 | 488篇 |
预防医学 | 369篇 |
眼科学 | 26篇 |
药学 | 452篇 |
1篇 | |
中国医学 | 209篇 |
肿瘤学 | 168篇 |
出版年
2024年 | 34篇 |
2023年 | 247篇 |
2022年 | 187篇 |
2021年 | 439篇 |
2020年 | 417篇 |
2019年 | 391篇 |
2018年 | 408篇 |
2017年 | 389篇 |
2016年 | 340篇 |
2015年 | 338篇 |
2014年 | 461篇 |
2013年 | 492篇 |
2012年 | 393篇 |
2011年 | 414篇 |
2010年 | 378篇 |
2009年 | 376篇 |
2008年 | 427篇 |
2007年 | 403篇 |
2006年 | 379篇 |
2005年 | 375篇 |
2004年 | 333篇 |
2003年 | 304篇 |
2002年 | 262篇 |
2001年 | 323篇 |
2000年 | 173篇 |
1999年 | 250篇 |
1998年 | 281篇 |
1997年 | 231篇 |
1996年 | 271篇 |
1995年 | 243篇 |
1994年 | 229篇 |
1993年 | 195篇 |
1992年 | 200篇 |
1991年 | 187篇 |
1990年 | 161篇 |
1989年 | 174篇 |
1988年 | 176篇 |
1987年 | 135篇 |
1986年 | 135篇 |
1985年 | 124篇 |
1984年 | 93篇 |
1983年 | 96篇 |
1982年 | 66篇 |
1981年 | 32篇 |
1980年 | 45篇 |
1979年 | 39篇 |
1978年 | 30篇 |
1977年 | 29篇 |
1976年 | 26篇 |
1975年 | 29篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
1.
2.
3.
4.
5.
Jennifer J. Schoch Reesa L. Monir Kerrie G. Satcher Jessica Harris Eric Triplett Josef Neu 《Pediatric dermatology》2019,36(5):574-580
Recent focus on the neonatal intestinal microbiome has advanced our knowledge of the complex interplay between the intestinal barrier, the developing immune system, and commensal and pathogenic organisms. Despite the parallel role of the infant skin in serving as both a barrier and an interface for priming the immune system, large gaps exist in our understanding of the infantile cutaneous microbiome. The skin microbiome changes and matures throughout infancy, becoming more diverse and developing the site specificity known to exist in adults. Delivery method initially determines the composition of the cutaneous microbiome, though this impact appears transient. Cutaneous microbes play a critical role in immune system development, particularly during the neonatal period, and microbes and immune cells have closely intertwined, reciprocal effects. The unique structure of newborn skin influences cutaneous microbial colonization and the development of dermatologic pathology. The development of the infantile skin barrier and cutaneous microbiome contributes to future skin pathology. Atopic dermatitis flares and seborrheic dermatitis have been linked to dysbiosis, while erythema toxicum neonatorum is an immune response to the establishment of normal bacterial skin flora. Physicians who care for infants should be aware of the impact of the infantile skin microbiome and its role in the development of pathology. A better understanding of the origin and evolution of the skin microbiome will lead to more effective prevention and treatment of pediatric skin disease. 相似文献
6.
7.
《European journal of surgical oncology》2019,45(11):2090-2095
BackgroundWe sought to identify treatment disparities existing prior to publication of the 2015 American Thyroid Association Management Guidelines in order to identify patients with papillary thyroid cancer (PTC) at risk for receiving inadequate treatment.MethodsPatients diagnosed with PTC from 2011 to 2013 were identified using Surveillance, Epidemiology and End Results database. High-risk disease was defined as T4, N1, or M1. Chi-square tests compared characteristics of patients with and without high-risk disease and characteristics of high-risk patients who did and did not receive radioactive iodine ablation (RAI). Likelihoods of having high-risk disease, of receiving RAI, and of cause-specific death were calculated using regression analyses.ResultsSample included 32,229 individuals; 7894 (24.5%) had high-risk disease. Mean age was 50.0 years, 24,815 (77.0%) were female, and 21,318 (66.2%) were white. Odds of high-risk disease were greater among males (OR:2.04; 95% CI:1.92–2.16), Hispanics (OR:1.67; 95% CI:1.56–1.79) and Asians (OR:1.49; 95% CI:1.37–1.62), and uninsured (OR:1.24; 95% CI:1.07–1.43), and lower among patients ages 45–64 (OR:0.57; 95% CI:0.53–0.60), and ≥65 years (OR:0.54; 95% CI:0.50–0.59), and Blacks (OR:0.46; 95% CI:0.40–0.53). Most (69.3%) high-risk patients received RAI. Odds of receiving RAI were lower among patients age ≥65 years (OR:0.67; 95% CI:0.58–0.77), uninsured (OR:0.52; 95% CI:0.41–0.67), or with Medicaid (OR:0.58; 95% CI:0.50–0.69). RAI use reduced the risk of cause-specific mortality (HR:0.29; 95% CI:0.18–0.47).ConclusionKnowledge of these treatment disparities will allow recognition of groups at risk for high-risk disease and receiving inadequate treatment. 相似文献
8.
9.
10.